Eagle Pharmaceuticals
EGRX
#10434
Rank
NZ$8.56 M
Marketcap
NZ$0.66
Share price
0.00%
Change (1 day)
-43.42%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: NZ$8.56 Million

As of January 2026 Eagle Pharmaceuticals has a market cap of NZ$8.56 Million. This makes Eagle Pharmaceuticals the world's 10434th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$8.56 M-14.95%
2025NZ$10.06 M-20.33%
2024NZ$12.63 M-88.23%
2023NZ$0.10 B-82.08%
2022NZ$0.59 B-37.76%
2021NZ$0.96 B14.47%
2020NZ$0.84 B-30.83%
2019NZ$1.21 B45.49%
2018NZ$0.83 B-25.54%
2017NZ$1.12 B-36.68%
2016NZ$1.77 B-12.5%
2015NZ$2.02 B629.53%
2014NZ$0.27 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
NZ$8.56 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$856.39 B 10,000,371.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$177.11 B 2,068,094.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
NZ$472.31 B 5,515,311.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
NZ$63.86 B 745,707.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
NZ$305.38 B 3,565,985.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.658 T 19,362,434.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$197.76 B 2,309,287.82%๐Ÿ‡บ๐Ÿ‡ธ USA